AKL’s business model is led by a small group of executives accessing expert opinion to guide corporate strategy and product development

These key advisors are recognised experts in their field and used extensively to guide AKL’s corporate, preclinical and clinical strategy.


Dr. Annalisa Jenkins
Former Executive VP and Global Head Research & Development Merck Serono, SVP and Head of Global Medical Affairs BMS. Linkedin


Prof. Frank Bonner
Former Director of Science & Technology, Huntingdon Life Sciences. Former President of British Toxicology Society. Linkedin


John McCrerie
Former Technical Director of Becpharm Limited; Senior Manager and International QA Director Wellcome Glaxo